DJ Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Wednesday When Compared To Competitors Despite Daily Gains
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Corbus Pharmaceuticals Holdings Inc. $(CRBP)$ advanced 2.16% to $8.05 Wednesday, on what proved to be an all-around poor trading session for the stock market, with the NASDAQ Composite Index falling 1.34% to 26,021.66 and Dow Jones Industrial Average falling 0.98% to 51,492.55.
Corbus Pharmaceuticals Holdings Inc. closed 60.85% below its 52-week high of $20.56, which the company reached on October 20th.
The stock underperformed when compared to some of its competitors Wednesday, as Vanda Pharmaceuticals Inc. $(VNDA)$ rose 4.01% to $5.96, Fortress Biotech Inc. (FBIO) rose 4.78% to $3.07, and Viking Therapeutics Inc. (VKTX) rose 2.16% to $30.29.
Trading volume (278,957) remained 198,629 below its 50-day average volume of 477,586.
Data source: Dow Jones Market Data, FactSet. Data compiled June 17, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
June 17, 2026 17:19 ET (21:19 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.
Comments